Received Apr 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | LA |
New gluten allergy; This is a spontaneous report received from a Consumer or other non HCP. A 22-year-old female patient (not pregnant) received BNT162b2 (COMIRNATY), on 06Jul2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 31Jul2021 as dose 2, single (Batch/Lot number: unknown) at the age of 22 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: BLISOVI 24 FE. The following information was reported: GLUTEN SENSITIVITY (non-serious) with onset Nov2021, outcome "not recovered", described as "New gluten allergy". Therapeutic measures were not taken as a result of gluten sensitivity. Additional information: The patient received their vaccine at a school or student health clinic. No other vaccines were administered on the same date, nor were any other vaccines received in the four weeks prior to this appointment. However, the patient was taking other medications within two weeks of the onset of the event. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
BLISOVI 24 FE